Riskpilot← Back to searchSign inGet full accessAKamali AB
ABActiveOrg 5569704884Sonja Kovalevskys Gata 4General medical practice activities · NACE 8621Est. 20140 employees
Revenue 2024
SEK 0
EBITDA margin
—
+75% vs 2023
Equity ratio
-615.1%
Financial strength
Net profit 2024
SEK -2K
+76% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -3K | +75% |
| Net profit | SEK -2K | +76% |
| Total assets | SEK 60K | +4% |
| Equity | SEK -370K | -1% |
| Employees | 0 | — |
Legal name
AKamali AB
Org number
5569704884
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 maj 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Läkarverksamhet för förebyggande hälsovård, medicinsk rådgivning, föreläsning, utbildning, konsultverksamhet och därmed förenlig verksamhet samt handel med värdepapper. Forskning inom medicinska områden. Kirurgiska och icke kirurgiska ingrepp mot åderbråck.
Address
Sonja Kovalevskys Gata 4
Email
alexander@akademisktcentrum.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −30 | −29 | −11 | −10 | −3 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −30 | −29 | −11 | −10 | −3 |
| Net financials | — | — | −0 | 0 | 0 |
| Profit before tax | −30 | −29 | −11 | −10 | −2 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −30 | −29 | −11 | −10 | −2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 55 | 68 | 63 | 58 | 60 |
| Equity | −316 | −346 | −357 | −367 | −370 |
| Long-term debt | 349 | 349 | 349 | 349 | 354 |
| Short-term debt | 22 | 65 | 71 | 76 | 76 |
| Total debt | 371 | 414 | 420 | 425 | 430 |
EBITDA margin
-257500.0%
This company
15.8%
Market median
-1629847% vs market
20202024
Equity ratio
-615.1%
This company
38.2%
Market median
-1710% vs market
20202024
Return on equity
-245800.0%
This company
18.4%
Market median
-1335970% vs market
20202024
Net profit margin
-245800.0%
This company
8.1%
Market median
-3034668% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AA Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
SS Chief Executive Officer | Chief Executive Officer | 2024 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2024 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AKamali AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexander Arsha Kamali | Chief Executive Officer | 0 companies |
| Sayid Sebastian Sam Zommorodi | Chief Executive Officer | 0 companies |
| Lina Ingalill Johanna Zommorodi | Deputy Board Member | 0 companies |
| Simin Dokht Bolourian | Deputy Board Member | 0 companies |